FDA issues Emergency Use Authorizations for two animal drugs to prevent and treat New World screwworm infestations in livestock, poultry, and exotic animals following HHS's August 18, 2025 public health emergency declaration.
Federal agencies are reviewing multiple forms for paperwork reduction compliance under the Paperwork Reduction Act; public comment period open for burden reduction assessments.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
CDC seeks public comment on the Public Health Emergency Management Tool data collection under the Paperwork Reduction Act of 1995 to assess emergency management capacity in partner countries.
Federal agencies are reviewing multiple forms under the Paperwork Reduction Act to reduce burden on small businesses and other respondents.
Federal agency forms are undergoing Paperwork Reduction Act review to assess burden on small businesses and other respondents.
FAA announces charter renewal and membership nominations for the National Airspace System Advisory Committee, which advises on air traffic management systems and integration of new aviation technologies.
U.S. Department of Commerce issues countervailing duty orders on certain chassis and subassemblies from Mexico and Thailand following affirmative trade injury determinations.
Center for Scientific Review will hold closed meetings to review and discuss NIH grant applications and related administrative matters on specified dates.
HUD seeks OMB approval for a public housing waiting list data collection tool under the Housing Opportunity Through Modernization Act; public comment period ends 30 days from publication.
FDA withdraws approval of SpecGx LLC's abbreviated new drug application for Methylphenidate Hydrochloride Extended-Release tablets in 27mg, 36mg, and 54mg strengths per the applicant's request.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
